ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MRVI Maravai LifeSciences Holdings Inc

4.77
-0.17 (-3.44%)
04 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Maravai LifeSciences Holdings Inc NASDAQ:MRVI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.17 -3.44% 4.77 4.77 4.88 5.10 4.76 4.97 1,787,467 23:55:51

Maravai LifeSciences Announces November 2024 Investor Conference Schedule

12/11/2024 1:05pm

GlobeNewswire Inc.


Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart


From Nov 2024 to Feb 2025

Click Here for more Maravai LifeSciences Charts.

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in November.

On November 19, 2024, at 8:30 a.m. PST/ 11:30 a.m. EST, Kevin Herde, Chief Financial Officer, and Drew Burch, President, Nucleic Acid Production, will participate in a fireside chat at the Stifel Healthcare Conference in New York, NY.

On November 21, 2024, at 2:00 a.m. PST/ 9:00 a.m. GMT, Trey Martin, Chief Executive Officer, and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in London, England.

A live webcast of each presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, Upcoming events. An archived version of the webcast will also be available on the Maravai website after the event is completed.

About Maravai

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.

For more information about Maravai LifeSciences, visit www.maravai.com.

Contact Information:

Investor Contact:
Deb Hart
Maravai LifeSciences
+1 858-988-5917
ir@maravai.com

1 Year Maravai LifeSciences Chart

1 Year Maravai LifeSciences Chart

1 Month Maravai LifeSciences Chart

1 Month Maravai LifeSciences Chart

Your Recent History

Delayed Upgrade Clock